Correlation Between MERCK Kommanditgesells and Takeda Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both MERCK Kommanditgesells and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MERCK Kommanditgesells and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MERCK Kommanditgesellschaft auf and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on MERCK Kommanditgesells and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MERCK Kommanditgesells with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of MERCK Kommanditgesells and Takeda Pharmaceutical.
Diversification Opportunities for MERCK Kommanditgesells and Takeda Pharmaceutical
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between MERCK and Takeda is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding MERCK Kommanditgesellschaft au and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and MERCK Kommanditgesells is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MERCK Kommanditgesellschaft auf are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of MERCK Kommanditgesells i.e., MERCK Kommanditgesells and Takeda Pharmaceutical go up and down completely randomly.
Pair Corralation between MERCK Kommanditgesells and Takeda Pharmaceutical
Assuming the 90 days horizon MERCK Kommanditgesellschaft auf is expected to generate 2.21 times more return on investment than Takeda Pharmaceutical. However, MERCK Kommanditgesells is 2.21 times more volatile than Takeda Pharmaceutical Co. It trades about 0.01 of its potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.01 per unit of risk. If you would invest 17,460 in MERCK Kommanditgesellschaft auf on January 25, 2024 and sell it today you would lose (1,409) from holding MERCK Kommanditgesellschaft auf or give up 8.07% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 99.8% |
Values | Daily Returns |
MERCK Kommanditgesellschaft au vs. Takeda Pharmaceutical Co
Performance |
Timeline |
MERCK Kommanditgesells |
Takeda Pharmaceutical |
MERCK Kommanditgesells and Takeda Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MERCK Kommanditgesells and Takeda Pharmaceutical
The main advantage of trading using opposite MERCK Kommanditgesells and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MERCK Kommanditgesells position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.MERCK Kommanditgesells vs. Holloman Energy Corp | MERCK Kommanditgesells vs. cbdMD Inc | MERCK Kommanditgesells vs. Evolus Inc | MERCK Kommanditgesells vs. CV Sciences |
Takeda Pharmaceutical vs. Silver Spike Investment | Takeda Pharmaceutical vs. Alkermes Plc | Takeda Pharmaceutical vs. Eagle Pharmaceuticals | Takeda Pharmaceutical vs. Evotec SE ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
CEOs Directory Screen CEOs from public companies around the world | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |